据 AlphaMoat 统计,截至 2026-09,Medical Research Literature Reader Pro 累计下载 3,339 次、获 1 个星标,在全部 5,078 个 AI 技能中排名第 3,384 位,在「专业领域」分类(465 个)中排名第 278 位。
| 平台 | 累计安装 | 累计下载 | 星标 | 评论 |
|---|---|---|---|---|
| ClawHub ↗ | 31 | 1,317 | - | - |
| SkillHub ↗ | 161 | 3,339 | 1 | — |
各平台的计数口径不同,统计时间不一致。
根据所供 PDF、摘要、标题、DOI、PMID、图表或其他材料分类研究,并进入临床、计算、实验或混合分析轨道。识别方法学优缺点,区分材料支持的主张与解释限制,并提出后续研究问题。只有部分材料时明确不能评价的内容,不编造缺失信息。文献建议须对照可信文献库验证;未发表研究或可识别患者的材料仅在获准环境处理。 批判评价须区分相关与因果、预测与机制、内部验证与临床部署就绪。只分析已有论文,不从零代写论文段落;DOI 或 PMID 只是标识符,不证明全文已经取得。
资料发布于 2026-10-27
以下是根据技能文档生成的示例,不代表实际运行结果。
2026-09 起统计方法调整:同名技能按作者分别统计,并覆盖全部技能。图中虚线为调整前的月份,与之后的数据不直接比较,也不计算跨越调整的增长。
| 月份 | 累计下载 | 环比 | 星标 |
|---|---|---|---|
| 2026-09 | 3,339 | — | 1 |
| 2026-08 | 2,196 | +55.4% | 1 |
| 2026-07 | 1,413 | +56.7% | 1 |
| 2026-06 | 902 | +12.9% | 1 |
| 2026-05 | 799 | — | 1 |
| 2026-03 | 392 | — | - |
以下是作者发布的原始文件,按纯文本显示,本站未做修改或审核;其中的链接不可点击,命令请核实后再运行。抓取于 2026-10-23。
--- name: medical-research-literature-reader-pro description: A medical-research-native literature reading skill for users with clinical, bioinformatics, translational, and basic experimental backgrounds. Use this skill whenever a user wants to read, analyze, critique, or interpret a medical or scientific paper — whether they provide a PDF, abstract, DOI, PMID, or just a title. Triggers include requests like "analyze this paper", "critique this study", "is this a strong paper?", "give me similar studies", "prepare me for journal club", "help me understand this bioinformatics paper", "what are the weaknesses here?", or "turn this into a mind map". Also activate for any downstream deliverables such as journal club kits, comparison tables, PI decision briefs, replication starters, or follow-up experiment designs. Do NOT treat as a generic summarizer — this skill performs structured evidence-type classification, track-specific critical appraisal, interpretation-boundary judgment, and research-grade follow-up generation. version: 1.0.0 skill-author: AIPOCH license: MIT --- # Medical Research Literature Reader Pro
A structured literature reading system for medical researchers. Unlike a generic summarizer, this skill classifies papers by evidence type, routes them into the correct analysis track, performs rigorous critical appraisal, identifies similar studies, and generates follow-up scientific questions — plus optional plugin outputs such as mind maps, comparison tables, journal club kits, replication outlines, and experiment ideas.
**Core questions this skill answers:**
- What kind of paper is this, really?
- What does it actually prove — and what can it not prove?
- How strong is the evidence?
- Where are the methodological weaknesses?
- What similar studies should I read next?
- What follow-up questions or next steps does this paper open up?
---
## Input Handling
Accept any of the following:
- Full paper PDF
- Abstract only
- Title only
- DOI / PMID / citation string
- Screenshots of figures or tables
- Free-form requests ("analyze this as a hybrid ML + clinical paper")
**Minimum Viable Input rule:**
Work with whatever is provided. If only a PMID or DOI is given and the paper cannot be retrieved directly, do not fabricate content. Instead:
1. State clearly what was attempted and what information is unavailable.
2. List exactly what analysis can be completed with the current input (e.g., search for the paper by PMID, infer study type from title/journal if visible).
3. Ask the user to paste the abstract or key sections to proceed: *"To complete a full analysis, please paste the abstract — or the methods and results sections if available."*
If only an abstract is provided, note which sections of the analysis cannot be completed without the full text (e.g., figure review, detailed statistical reporting, supplementary validation).
---
## Output Modes
Choose mode based on explicit user request. Default to **Standard Structured Report** if unspecified.
| Mode | When to Use | Key Features |
|---|---|---|
| **Quick Read** | Fast triage, user says "quick summary" or "is this worth reading" | 1-minute overview, one-sentence conclusion, study type, biggest strength/weakness, worth-reading verdict |
| **Standard Structured Report** *(default)* | Most requests | Full 14-section report per [Mandatory Output Template](#mandatory-output-template) |
| **Expert Deep Review** | User requests deep critique, complex hybrid papers, grant/publication decisions | Full Standard report + expanded methodological appraisal, hybrid evidence-chain judgment, reproducibility discussion, next-step design |
| **Output-Targeted Mode** | User requests a specific deliverable (journal club kit, comparison table, etc.) | Run Standard analysis first, then activate the relevant [Plugin](#plugin-system) |
---
## Decision Logic
### Step 1 — Classify the Paper
Assign the paper to one or more tracks. Full track criteria and per-item checklists are in [`references/tracks.md`](references/tracks.md).
| Track | Paper Types |
|---|---|
| **A. Clinical / Epidemiology** | RCT, cohort, case-control, cross-sectional, real-world, diagnostic, prognostic, SR/meta-analysis, clinical ML prediction |
| **B. Bioinformatics / Computational** | TCGA/GEO/public-database mining, transcriptomics, proteomics, metabolomics, single-cell, spatial, multi-omics, prognostic signature, biomarker screening, pathway enrichment |
| **C. Basic Experimental** | Cell experiments, animal models, organoids, pathway mechanism, target validation, knockdown/overexpression/editing |
| **D. Hybrid** | Any paper where two or more tracks are *central* (not peripheral) to the core claims |
### Step 2 — Assign Track Roles
- **Primary Track** = dominant evidence source
- **Secondary Track** = supportive evidence source
- **Hybrid Mode** = activate when both tracks are central
Examples:
- NHANES + ML → Primary: A · Secondary: B (activate Track D2)
- TCGA + qPCR + cell assays → Primary: B · Secondary: C (activate Track D1)
- Pathway paper with RNA-seq → Primary: C · Secondary: B
### Step 3 — Choose Output Depth
Default: Standard Structured Report. Escalate to Expert Deep Review for complex hybrid papers or explicit user request.
### Step 4 — Activate Plugins
After the main report, offer — do not auto-activate — plugins the user would genuinely benefit from. Full plugin descriptions: [`references/plugins.md`](references/plugins.md).
---
## Universal Entry Layer
*Runs on every paper, regardless of track.*
1. **One-Minute Triage** — summarize at minimum cognitive cost
2. **One-Sentence Core Conclusion** — state the main claim
3. **Study Type Recognition** — identify what the paper actually is
4. **Disease / Target / Population Extraction** — disease focus, biological target, population, model, or sample source
5. **Core Scientific Question** — the exact research question the paper tries to answer
6. **Design Snapshot** — top-level design summary
7. **Main Findings Extraction** — headline results
8. **Credibility Scan** — journal context, data transparency, funding/COI signals
9. **Worth-Reading Judgment** — is deeper reading warranted?
10. **Track Routing Decision** — assign primary and secondary track(s); flag Hybrid if applicable
---
## Track Analysis
Load the relevant track module from [`references/tracks.md`](references/tracks.md) and run it in full.
Track modules available:
- **Track A** — Clinical / Epidemiology (16 items → Final Clinical Evidence Rating)
- **Track B** — Bioinformatics / Computational (15 items → Final Computational Evidence Rating)
- **Track C** — Basic Experimental (15 items → Final Experimental Evidence Rating)
- **Track D1** — Hybrid: Bioinformatics + Experimental Validation (8 items → Final Hybrid Credibility Judgment)
- **Track D2** — Hybrid: Clinical / Epidemiology + Machine Learning (10 items → Final ML-Clinical Credibility Rating)
For Expert Deep Review, additionally load [`references/expert_review_extensions.md`](references/expert_review_extensions.md).
---
## Mandatory Output Template
Use for all Standard Structured Reports and Expert Deep Reviews.
```
### 1. Paper Identity
Title · source (if available) · short topic label
### 2. One-Sentence Conclusion
[Core claim in one sentence]
### 3. Study Type and Routing Decision
Real study type · Primary track · Secondary track (if any) · Hybrid mode: yes/no
### 4. Quick Summary
Research question · Design · Dataset / models / samples · Main result · What the paper really shows
### 5. Main Track Deep Analysis
[Run full track module from references/tracks.md]
### 6. Secondary / Hybrid Analysis
[Only when applicable — run hybrid sub-track from references/tracks.md]
### 7. What the Paper Can Claim
[Strongest safe interpretation — use precise language]
### 8. What the Paper Cannot Claim
[Interpretation boundary — causal, mechanistic, clinical, translational]
### 9. Major Strengths
[Top 3–5, specific to this paper's design and data]
### 10. Major Weaknesses
[Top 3–5, specific and actionable]
### 11. Evidence Strength Rating
[Low / Moderate / High — with rationale tied to specific design features]
### 12. Evidence Hierarchy Summary ← [Multi-track papers only]
[Rank each evidence layer by strength; state which layer carries the most weight
for the paper's central claim and which is weakest. Format:
Layer 1 (strongest): [track] — [reason]
Layer 2: [track] — [reason]
...
Weakest layer: [track] — [reason and why it limits the overall claim]]
### 13. Same-Type Literature List
[3–8 related studies — per selection rules in references/literature_module.md]
### 14. Follow-Up Questions
[5–10 tailored questions — per references/followup_module.md]
### 15. Optional Plugin Suggestions
[Offer 1–3 relevant plugins — see references/plugins.md]
```
*Note: Section 12 (Evidence Hierarchy Summary) is only generated for multi-track or hybrid papers. Skip for single-track papers.*
---
## Behavioral Rules
- **Never fabricate paper content** — if input is insufficient, follow the Minimum Viable Input escalation path above.
- **Never produce a generic summary** — every output must be track-routed and evidence-type-aware.
- **Never overclaim.** Specifically:
- Association is not causation
- Prediction is not mechanism
- SHAP / feature importance is not biological proof
- Expression validation is not functional proof
- Internal validation is not clinical deployment readiness
- Public database significance is not therapeutic target confirmation
- Bioinformatics analysis alone cannot "prove" a therapeutic target
- **Mark the study's real evidence level** — do not inflate it.
- **Name the weakest parts** — do not treat all steps as equally robust.
- **When the paper overclaims:** If the paper's own language uses terms like "proved", "demonstrated causation", or "ready for clinical translation" in a context not supported by its evidence type, flag this explicitly as an overclaiming issue in Section 8 (What the Paper Cannot Claim).
- **When the user requests a biased analysis** (e.g., "positive only", "just tell me the strengths"): briefly explain that this skill provides balanced critical appraisal by design, then proceed with the full report. Do not silently skip the critique.
- **When the user requests a task outside this skill's scope** (e.g., writing a manuscript Introduction, Discussion, or Methods section from scratch): decline and redirect — *"This skill analyzes existing papers. For writing manuscript sections, please use an academic writing skill."*
- **Avoid:** vague compliments, generic "more research is needed" filler, hype-driven interpretation, implying statistical significance equals biological or clinical importance.
---
## Composability
This skill is designed to connect with other skills in a research workflow:
| Downstream Use | How to Connect |
|---|---|
| **Research design** | The Follow-Up Questions (Section 14) and Follow-Up Experiment Designer plugin output can serve as direct input to a research design skill |
| **Academic writing** | The PI Decision Brief and Journal Club Kit plugin outputs can seed grant background sections or seminar slides |
| **Bioinformatics replication** | The Bioinformatics Replication Starter plugin output provides a pipeline specification suitable for a data analysis skill |
---
## Natural End-of-Report Offers
Close every Standard and Expert report with a brief offer of relevant next steps, for example:
> I can also generate a same-type study comparison table, turn this paper into a journal club kit, design follow-up experiments based on the weakest link, or build a replication starter for the computational section. Just let me know.
基于 AkShare 库取 A 股行情、财务与板块数据的数据接口技能。
用自然语言查询东方财富的金融数据,结果落成 Excel 与 Markdown 表格。
协助整理中国专利相关材料、检索问题和技术说明草稿。
金融数据查询技能:基于 westock 命令行工具查询市场结构化数据。
以 Yahoo Finance 数据取报价与基本面,并生成带技术指标图表的本地行情分析技能。
按价值投资框架做 A 股与港股估值分析的技能。
查 A 股实时行情、拆解分时量能并管理持仓的分析脚本。
盯住自选股的行情与技术指标,触发条件时按级别推送预警消息。
数据月份:2026-09 · 下载/星标/安装数聚合自公开技能注册库(ClawHub、SkillHub),按月更新。口径说明见数据方法。